Trodelvy Improves Quality of Life Over Chemo in TNBC

Trodelvy led to better disease control and improved quality of life compared to chemotherapy in patients with triple-negative breast cancer.

Related Keywords

United States ,American ,Aditya Bardia ,Health Jonsson Comprehensive Cancer Center ,Department Of Medicine ,American Society Of Clinical Oncology Annual Meeting ,Translational Research Integration ,Drug Administration ,Clinical Oncology Annual ,Jonsson Comprehensive Cancer ,